CHINA PHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 25.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-11-12
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2025-03-31 was 25.00%.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 25.00%, a 0.00% change from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 25.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|---|---|---|
| 2025-09-30 | 25.00% 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 25.00% 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 25.00% 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 25.00% 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 25.00% 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | 25.00% 10-Q · filed 2024-08-14 | |||
| 2023-12-31 | 25.00% 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |